Basel (ots/PRNewswire) - - Avastin Offers Patients the Chance to Live Twice as Long Without Their Disease Advancing Avastin (bevacizumab), Roche's innovative anti-cancer drug, was approved today in Europe for the first-line treatment of patients with advanced renal cell cancer (RCC) in combination with interferon (IFN), the current standard of care[*]. ...
Mountain Province Diamonds Inc
Toronto and New York (ots/PRNewswire) - - Joint Venture Approves CAD$38 Million Budget for 2008 - 2008 Tuzo Bulk Sampling Program Commences - Shares Issued and Outstanding: 59,788,881 TSX: MPV AMEX: MDM Mountain Province Diamonds Inc ("the Company") (TSX: MPV, AMEX: MDM) today provided an update on progress at the Gahcho Kué diamond project in Canada's Northwest Territories, which is a joint ...
Mississauga, Canada (ots/PRNewswire) - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) and Grupo Ferrer Internacional, S.A. ("Ferrer"), a leading European pharmaceutical and medical devices company, today announced the receipt of initial orders for Vasogen's Celacade(TM) System in Germany. Celacade, a first-in-class therapy, is the only CE Mark approved product that ...
Malvern, Pennsylvania (ots/PRNewswire) - - Solstice Neurosciences, Inc. Launches a Self-Guided Lesson as Prep for In-Person Workshops In recognition that physician comfort and knowledge with techniques around botulinum toxin injections lead to the best results for patients with cervical dystonia (CD), Solstice Neurosciences, Inc. (Solstice) has created ...
Trappes, France (ots/PRNewswire) - - Sales Reach 100,000 in Nine Months Nissan's compact crossover, the Qashqai has just hit the landmark of 100,000 customer sales in Europe. Sales began in March and the 100,000th customer sale was completed during the last week of November. The UK, Russia and Italy are the Qashqai's three largest markets, with sales at the end of November of 17,554, 15,376 and 10,746 ...
Calgary, Canada (ots/PRNewswire) - - New Class of ApoA-I/HDL Drugs to Reverse Atherosclerosis Enters the Clinic Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that it has received approval by the US Food and Drug Administration (FDA) to initiate a Phase 1a clinical trial of oral RVX-208 in the USA. RVX-208 is a novel first-in-class small ...
Zürich (ots) - - Sales of 2,004,172 units from January to November beat last year's total with a month to spare - GM Europe YTD share up 0.3 point, at 9.5 percent - GM Europe YTD sales 157,282 vehicles ahead of last year - YTD: Opel/Vauxhall grows 4 percent, Chevrolet up 32 percent General Motors (GM) Europe set a new all-time record, with sales of 2,004,172 vehicles from January to ...
Malmoe, Sweden (ots/PRNewswire) - TAT today announced that Motorola has signed an agreement to license the TAT Cascades user interface framework for use on select mobile devices. TAT Cascades is a UI technology that enables the creation of a variety of application UIs with less effort and reduced lead times, and that allows for easy customisation of the UIs, tailored for different market target segments or device types. "The user interface has become one of the ...
Hilversum, The Netherlands (ots/PRNewswire) - - World first! Today, 6 December, Dutch broadcasting companies Radio Netherlands Worldwide and IKON in Hilversum are launching a world first: the integral texts of the Bible and the Qu'ran alongside each other on one website. The site appears in Dutch, English and Arabic at the same time. The objective of the ...
Toronto, Canada (ots/PRNewswire) - Gedex, a private Canadian corporation, and Anglo American plc are pleased to announce they have established a multi year strategic alliance aimed at developing and exploiting Gedex's next generation resource exploration system. The new proprietary multi-axis Gedex High Definition Airborne Gravity Gradiometer (HD-AGG(TM)), which is expected to be a breakthrough airborne survey ...
San Jose, California (ots/PRNewswire) - - The only reliable way to protect against counterfeiters - locking product authenticity in hardware Atmel(R) Corporation (Nasdaq: ATML) announced today CryptoRF(R), the world's first 13.56 MHz RFID devices with a 64-bit embedded cryptographic engine, mutual authentication capability, and up to 16 individually configurable zones. These devices prevent ...
Heilbronn, Germany (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of its feature-rich, competitively priced, UHF ASK/FSK receiver/transmitter family ATA8x0x. Applications include remote controls for consumer and industrial systems, access control, alarm and telemetry systems, energy metering, and home automation as ...
Stuttgart, Germany, November 29 (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of its AVR(R) 32-bit FlexRay(R) evaluation environment. In addition, Atmel will demonstrate its new technology today at the FlexRay day conference held in Stuttgart, Germany with a mockup car implementing advanced in-vehicle networking with ...
Leipzig, Germany, November 29 (ots/PRNewswire) - - Ophthalmic Clinic in Germany First in Europe To Treat Patients With New Focused Radiation Therapy NeoVista, Inc. announced today that the first European patient has been treated in the company's pivotal global clinical trial for its novel beta radiation epiretinal therapy for the wet form of age-related ...
Vancouver, Canada, November 26 (ots/PRNewswire) - Mawson Resources Limited ("Mawson") TSXv - MAW; Frankfurt - MRY. Michael Hudson, President & CEO, announces that drilling has commenced at the Klappibacken uranium project in northwestern Sweden where a 4,000-metre diamond drill program has been planned for this winter. Significant near-surface and high-grade ...
Basel, Switzerland, November 16 (ots/PRNewswire) - - Avastin Offers Patients the Chance to Live Twice as Long Without Their Disease Advancing Roche announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for Avastin (bevacizumab) for ...
San Jose, California, November 14 (ots/PRNewswire) - - Facilitates Low-Cost, No-Risk Evaluation of CAP Capabilities Atmel(R) Corporation (Nasdaq: ATML) today announced the launch of the AT91CAP9A-STK Starter Kit for its CAP(TM) Customizable Microcontroller product family. The CAP Starter Kit is the ideal vehicle for low-cost, no-risk evaluation of the ...
Bill & Melinda Gates Foundation
Seattle, November 14 (ots/PRNewswire) - - New initiative to support prevention programs targeting high-risk groups The Bill & Melinda Gates Foundation announced today that it will commit US$50 million to work in partnership with the Chinese government and non-governmental organizations to expand HIV prevention efforts in China. The funding will increase ...
Paris and Rousset, France, November 13 (ots/PRNewswire) - - ARM SC100-based Product Ensures Highly Secure Digital Transactions Atmel(R) Corporation (Nasdaq: ATML), announced today the introduction of its AT91SC464384RCU, the newest addition to the AT91SC Advanced Telecoms product family. Based on the ARM(R) SC100, this secure microcontroller targets mobile ...
Paris, November 13 (ots/PRNewswire) - Givex is pleased to announce today the international launch of Dynamic Currency Conversion (DCC) capability on gift cards. "This enhancement offers our multinational clients the flexibility to expand their gift card program into an international market," says Amanda French, Givex VP of Sales; "It also allows our clients ...
Paris and Rousset, France, November 12 (ots/PRNewswire) - - The AT98SC016CU is the newest addition to the AT98SC series of royalty and license-free secure solutions Atmel(R) Corporation (Nasdaq: ATML), announced today the introduction of the AT98SC016CU, the latest member of its AT98SC family of secure solutions specifically designed to address ...
Thalwil (OTS) - u-blox AG, the leading Swiss provider of GPS chips, modules and services, today announced the launch of two GPS modules that set new benchmarks in terms of speed, sensitivity and ease of integration. The LEA-5 GPS module series is based on u-blox' fifth generation positioning engine, u-blox 5, which boasts an acquisition performance of less than one second. These versatile, stand-alone GPS receivers ...
NHMRC Clinical Trials Centre - The University of Sydney
Sydney, November 7 (ots/PRNewswire) - In the Lancet, on Tuesday November, 6th new results of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) 2007 clinical trial have been published and presented on the same date at a press conference held during the AHA. - First lipid modifying agent shown to reduce the need for treatment of the leading ...
Lyon, France, November 6 (ots/PRNewswire) - Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today positive results in the development of a vaccine for the global prevention of dengue fever, one of the most widespread tropical diseases. The results are being presented today at the American Society of Tropical Medicine and Hygiene (ASTMH)'s ...
NHMRC Clinical Trials Centre - The University of Sydney
Sydney, November 6 (ots/PRNewswire) - - First Lipid Modifying Agent Shown to Reduce Risk of Leading Causes of Blindness and Deteriorating Vision in Patients With Type 2 Diabetes - Reduces Need for Laser Treatment in Patients With and Without Known Diabetic Retinopathy - Significantly Decreases Progression of Diabetic Eye Disease Fenofibrate is the ...
Orlando, Florida, November 5 (ots/PRNewswire) - Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce today key scientific data was presented in an oral presentation highlighting the novel features of RVX-208, at the American Heart Association Scientific Meetings. The presentation titled "Oral ...
Copenhagen, November 5 (ots/PRNewswire) - /OFF HOLD OFF HOLD OFF HOLD -- Bullguard Ltd, PIV279125 The following release: "BullGuard Releases Internet Security 8.0" is now OFF HOLD. Distribution time: 5 Nov 2007 10:00 GMT - More Backup, Less Spam and Even Better Support Today BullGuard releases its Internet Security 8.0, the latest version of BullGuard's flagship product. New features include a 5 gigabyte ...
Basel, Switzerland, November 5 (ots/PRNewswire) - -Low Haemoglobin Levels Associated With Increased Risk of Cardiovascular Disease and Death Data from the analysis of six major trials for the innovative new renal anaemia treatment MIRCERA, have shown that it effectively corrects and maintains haemoglobin ...
Paris (ots/PRNewswire) - - Novel Compound Offers Hope to Patients not Adequately Responding to Laxative Treatment Data presented for the first time today at the international gastroenterology meeting UEGW (United European Gastroenterology Week) confirm the effectiveness and safety of RESOLOR(R) ...
Vancouver (ots/PRNewswire) - - The Next Uranium Super-Cycle Will be Fueled by The Athabasca Basin With ESO Uranium's strategically selected land package encompassing 985,885 acres, the company is well-managed and financed, with CDN$6 million in working capital. ESO is now drilling on two locations in northern Saskatchewan, as we find out in this discussion with ESO's VP of Exploration, Ben Ainsworth and ...